**Company Registration No.** 07266955 **Charity No.** 1140616 

**British Association of Urological Nurses** 

**Company Limited by Guarantee** 

**Unaudited financial statements For the year ended 31 March 2026** 



## **British Association of Urological Nurses Company Limited by Guarantee For the year ended 31 March 2026** 

||**Page**|
|---|---|
|Trustees' Annual Report (Incorporating the Director's Report)|2-7|
|Independent examiner's report|8-9|
|Statement of financial activities (including Income and Expenditure account)|10|
|Statement of financial position|11|
|Statement of Cash flows|12|
|Notes to the financial statements|13-20|





## **British Association of Urological Nurses Company Limited by Guarantee For the year ended 31 March 2026** 

The trustees, who are also the directors for the purposes of company law, present their report and the unaudited financial statements of the charity for the year ended 31 March 2026 

|**Reference and administrative details**|**Reference and administrative details**|
|---|---|
|**Registered charity name**|British Association of Urological Nurses|
|**Charity number**|1140616|
|**Company number**|07266955|
|**Trustees**|Pauline Bagnall {appointed 16/11/2020}|
||Adele Brodie {resigned 17/11/25 }|
||Kelly Kusinski {appointed 4/11/24}|
||Deborah Victor {appointed 4/11/24}|
||Elizabeth Rowland {appointed 4/11/24}|
||Samantha McBeigh {appointed 4/11/24}|
||Hannah Doyle {appointed 4/11/24}|
||Laura Noble {appointed 17/11/25}|
||Ktasl Kaur {appointed 17/11/25}|
||Ameena Pradhan {Appointed 17/11/25}|
||Kelly Leonard {appointed 29/11/2021}|
||Carmen Hayes {resigned 22/01/26}|
||Sarah Hillery {resigned 17/11/2025}|
|**President**|Emma Chappel (appointed President 4/11/24)|
|**Secretary**|Kelly Leonard|
|**Registered office**|71 Queen Victoria Street|
||London|
||England|
||EC4V 4BE|
|**Principle office**|Fitwise Management Limited|
||Blackburn House|
||Seafield|
||West Lothian|
||EH47 7AQ|
|**Solicitors**|J F Dawson|
||34 Tisworth Road|
||Beaconsfield|
||Buckinghamshire|
||HP9 1TP|
|**Independent examiner**|Kenneth McDowell CA|
||Saffery LLP|
||9 Haymarket Square|
||Edinburgh|
||EH3 8RY|



Page 1 



**British Association of Urological Nurses Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) For the year ended 31 March 2026** 

## **Structure, governance and management** 

The British Association of Urological Nurses (BAUN) is both a company limited by guarantee, incorporated on 27th May 2010, and a registered charity with effect from 01 March 2011. BAUN was founded in 1995, it is a professional membership association for the promotion of education in urological nursing and urological patient care. 

The BAUN Trustees are the management group responsible for the daily management of the association and consists currently of members who are both directors under the companies act, as well as trustees under the charities act. It acts as both the professional body in the provision of education to its members and the business arm of the association. BAUN council derives its authority from the membership and from the ratification of the business plan at the association's annual general meeting. Annual General Meetings are held on a yearly basis during an annual conference. 

BAUN Trustees host council meetings four times per year. Trustees are elected onto the council by postal or electronic ballot by the full voting membership. The officers of the association are elected by the current trustees. The office of president is elected by postal or electronic ballot of all members of the association. BAUN council must comprise of at least 3 trustees. 

## **Objectives and activities** 

The charity's objects are specifically restricted to the promotion of the advancement of education in Urological Nursing and Urological patient care. 

Every trustee is personally responsible and accountable for the prudent management of the assets of the association and is required to work prudently in the interests of the charity. An annual return of accounts and activities is required and provided in the production of proper accounting records which disclose the reasonable accuracy, at any time during the financial year, the financial position of the charity. All such records relating to financial statements must comply with existing legislation and the association meets all its obligations in this respect. 

The aims of the association a charitable company, limited by guarantee as set out in the memorandum and articles of the association require the trustees / directors to discharge their responsibilities under the charities act 1996 and the companies Act 1996. 

## The BAUN aims are to: - 

1) Help to improve the care of urological patients in all healthcare settings 

2) Organise conferences and study days to help educate urological nurses 

3) Provide educational materials including guidelines, websites, newsletters for BAUN members 

4) Provide personal development opportunities for BAUN Members through involvement in running the association 

5) Work collaboratively with other organisations and exchange information and advice with them to the benefit of patients 

6) Alone or with other organisations nationally and internationally seek to influence the urological healthcare agenda 

Page 2 



## **British Association of Urological Nurses Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2026** 

## **Objectives and activities** (continued) 

## The BAUN Values are: 

B Business efficiency (Continuous improvement) 

A Accountability (Transparency / Trustees) 

U Urological Nursing Vision (holistic needs of all members -novice to expert) N National Representation / Networking (raising profile) 

The top 5 objectives for BAUN were: 

1. Association & Event Management Contract Renewal 

2. Future planning of events and meeting 

3.Succesion planning of Trustee roles 

- 4.Membership engagement 

- 5.Continuing education e.g. EFUN, Guidelines & Website development 

## **Achievements and performance** 

## Core Activities 

In addition to the President objectives the Core Activities of the association are: 

1. Annual Conference 

2. Educational Programme 

3. BAUN Newsletter 

4. BAUN Journal - International Journal of urological Nursing. 

5. Educational days (study days) 

6. Webinars 

## Other Aims 

1. Influence the development of (long term) project(s) to meet the aim of association 

2. Raise BAUN profile 

3. Collaborative working to the benefit of patients 

4. Influence and develop communications strategy within the association 

5. Develop governance processes to enable a pro- active approach and reduce risks to the association 

BAUN Annual conference and exhibition 2025 took place at the Edinburgh International Conference Centre (EICC) in Edinburgh, 16th – 18th November 2025. With 250 registered delegates; 55 exhibitors and 40 abstract submissions. 92% of delegates felt that the Conference met their expectations and 86% would recommend the BAUN conference to their colleagues. 

Page 3 



**British Association of Urological Nurses Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2026** 

## **Achievements and performance (continued)** 

## **Future of BAUN** 

BAUN trustees continue to meet 4 times a year, with January and June’s meetings in person, and April and Octobers meetings held virtually. In BAUN's January 2026 meeting, trustees met in person at the Prostate Cancer UK offices in London. 

BAUN's membership increased from £69K to £71K in 2025-26, there were 1,058 members as of 31 March 2026. BAUN continue to enhance members benefits by offering free webinars. 

BAUN Educational programme continue to host educational events out with the annual conference. The Education committee has successfully delivered another study day. Held at the Hilton, Belfast on Friday 6th June 2025, with 53 registered delegates: 9 exhibitors and 2 sponsors. 95% of delegates would recommend the Study Day to their colleagues and 95% felt the event met their expectations. The committee is currently arranging their next study day in Cardiff, Wales for the 6th June 2026. 

BAUN's conference organising group continue to arrange future educational conferences and has secured the following venues, Manchester Central for 2026 and Bournemouth International Centre for 2027. 

BAUN Newsletter continues to be fully digital, this is produced quarterly to its members, which provides up to date news on topical issues. lt generates income from advertising which finances the cost of producing the newsletter. This continues to be popular with members and enable a 2-way form of regular communication. The newsletter continues to be of immense credit to BAUN and a product to be proud of. 

The association provides the publication of The International Journal of Urological Nursing {IJUN) to its members. The journal continues to flourish worldwide with the new editorial committee having been integrated. Trustees are committed to ensure that the journal continues to be fit for purpose and meet the needs of the members and non- members of the association. 

BAUN Educational group continue to host free to members webinars. 5 were held within this finance year, topics including Metastic Bladder Cancer, Advancing Prostate Cancer Care, Space OAR, Quality of Life and the Nursing Role, Oncological Management of Renal Cancer, BAUN Intravesical Anti-Cancer Treatment Guideline (IVC) & LGNTQ+ Considerations in Urology. BAUN also released the following two guidelines to its members – Local Anaesthetic Transperineal Prostate (LATP) Biopsy & Intravesical Anti-Cancer Treatment (IVC) 

Page 4 



**British Association of Urological Nurses Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2026** 

## **Financial Review** 

For the year beginning 1 April 2025, the opening funds started the year with a surplus balance of £357K and ended the year with a balance of £408K as a result of £51K surplus for the year. 

## The restricted funds included; 

Bruce Turner Legacy Fund - £13,013 of which a net expenditure of £237 was utilised during this year. Cathrine Atkin Memorial Fund - £1,356 

The main contribution to the surplus was the success of the BAUN annual conference and exhibition, this generated a surplus of £64K, which will be used to reinvest in BAUN activities. 

At the beginning of the financial year for 2020/21 it was envisaged that BAUN would continue to keep monies in the investment, this is a low-risk approach as outlined in BAUN M&A's. The balance of funds invested with St James Place Wealth Management was £25,787 as at 31st March 2026. BAUN continue to review the investment to determine whether there is a requirement of a change to a medium risk. 

BAUN continue to host the IJUN virtually, which continues to be a cost saving from the previous hard copy issues. The income from Royalties is £27,585 as at 31st March 2026. 

BAUN continued to closely monitor the cash flow situation and took actions to avoid this dropping. Actions included; maximising credit terms and agreeing payment plans where possible. 

The management company representing us continued to help us draws up cash flow projections on a regular basis, and regular finance meetings are held with the BAUN treasurer. This helps BAUN to plan for their strategic aims in a staged way. 

## **Risk Management** 

BAUN trustees and directors have previously discussed the nature of BAUN potential risks and to ensure continuous improvement the risk register is reviewed at each quarterly board meeting. 

A monthly financial reporting process ensures that the directors and trustees are kept up to date with income and expenditure and are in a good position to pick up quickly on financial trends. Insurance is taken out to cover activity especially in respect to the annual conference. 

Page 5 



**British Association of Urological Nurses Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2026** 

BAUN highlighted 5 key objectives to achieve between 1 April 2025 and 31 March 2026 

## 1.Succession planning for trustee roles 

Role profiles have been reviewed by Trustees to ensure they are fit for purpose. Trustees identified where there were deputy leads required and these were implemented, with a new deputy treasurer, deputy education and deputy conference lead introduced. 

## 2. Create new BAUN website 

BAUN placed a tender call for website developers and following interviews, Pink Marketing, were appointed as the new developer. BAUN Trustees are working with PINK to develop an engaging and inclusive website, with external parties consulted on the content. BAUN were able to secure a grant from CURE to part fund this new development. 

## 3. Fundraising plan with Nova Fundraising 

BAUN worked with Nova Fundraising to assess their access to fundraising opportunities and to review how they currently promote their own fundraising efforts. Anthony Shanahan was appointed as the Fundraising Lead, which has now been distributed to Laura Noble {BAUN co-opted Trustee). BAUN have since decided to pause working with Nova Fundraising due to lack of opportunities. 

## 4. Equality, Diversity & Inclusion policy 

BAUN achieved their objective of producing an Equality, Diversity and Inclusion Policy. This objective will remain in place for 2025 - 2026 with three trustees having been appointed to lead on this policy. 

## 5. Engagement with other organisations including international 

BAUN Trustees have been actively engaging with charities and international organisations, BBUK, ACP, ANZUNS, EAUN, BAUS, PCUK, PCR. 

**BAUN has representation with the following organisations** 

|ACP Conference|IJUN|
|---|---|
|Action Bladder Cancer|KidneyCancer UK|
|Action KidneyCancer|National Prostate Cancer Audit|
|ANZUNS Conference|NICE|
|TUF|Prostate Cancer Research|
|BAUS Conference|PCUK|
|BAUS council meeting|PCUK Conference|
|BJN Awards ceremony/Juding|SUNA Conference|
|BHUK|UrologyNews|
|BBUK|APPG – ParliamentaryMeeting|
|British UrologyGroup (BUG)|Welsh Urology|
|DRIPP|Orchid|
|EAUN Conference|UKONS|
|EFUN|OUTpatients|
|Fight Bladder Cancer|Movember|
|Fowlers|RSM|
|GRIFT||



Page 6 



**British Association of Urological Nurses Company Limited by Guarantee Trustees' Annual Report (Incorporating the Director's Report) (continued) For the year ended 31 March 2026** 

## **Trustee's Responsibilities Statement:** 

The trustees, who are also directors for the purposes of company law, are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the charity trustees to prepare financial statements for each year which give a true and fair view of the state of affairs of the charitable company and the incoming resources and application of resources, including the income and expenditure, for the period. In preparing these financial statements, the trustees are required to: 

- •select suitable accounting policies and then apply them consistently; 

- •observe the methods and principles in the applicable Charities SORP; 

- •make judgements and accounting estimates that are reasonable and prudent; 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity w 

- continue in business. 

The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

## **Small Company Provisions** 

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies' exemption. The trustee's annual report was approved on 22.10.2026 and signed on behalf of the board of trustees by: - 

Emma Chappel BAUN President 2026-2027 

Page 7 



## **British Association of Urological Nurses Company Limited by Guarantee Independent examiner’s report For the year ended 31 March 2026** 

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2026. 

## **Respective responsibilities of trustees and examiner** 

As the charity’s trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’). 

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. 

## **Basis of independent examiner’s report** 

My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a ‘true and fair view’ and the report is limited to those matters set out in the statement below. 

## **Independent examiner’s statement** 

Since the Company’s gross income exceeded £250,000, your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of The Institute of Chartered Accounts of Scotland which is one of the listed bodies. 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe: 

1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

Page 8 



**British Association of Urological Nurses Company Limited by Guarantee Independent examiner’s report (continued) For the year ended 31 March 2026** 

## **Use of our report** 

This report is made solely to the charitable company’s members and the trustees, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our examination has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an independent examiner’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company, the charitable company’s members and trustees as a body, for our examination, for this report, or for the opinions we have formed. 


**Kenneth McDowell CA Saffery LLP Chartered Accountants** 28 October 2026 

9 Haymarket Square Edinburgh EH3 8RY 

Page 9 



## **British Association of Urological Nurses Company Limited by Guarantee** 

## **Statement of Financial Activities (including Income and Expenditure account) For the year ended 31 March 2026** 

|**Income and endowments**<br>**Notes**<br>Donations and legacies<br>4<br>Charitable activities<br>5<br>**Total income**<br>**Expenditure on:**<br>Charitable activities<br>6<br>Other expenditure<br>6<br>**Total expenditure**<br>Net gains/(losses) on investments<br>10<br>**Net income/ (expenditure)**<br>Transfers between funds<br>**Net movement in funds**<br>**Reconciliation of funds**<br>Total funds brought forward<br>**Total funds carried forward**|**Unrestricted**<br>**funds**<br>**£**<br>2,412<br>528,844<br>531,256<br>481,895<br>-<br>481,895<br>2,314<br>51,675<br>-<br>51,675<br>342,325<br>394,000|**Restricted**<br>**funds**<br>**£**<br>100<br>-<br>100<br>-<br>337<br>337<br>-<br>(237)<br>-<br>(237)<br>14,606<br>14,369|**Total funds**<br>**2026**<br>**£**<br>2,512<br>528,844<br>531,356<br>481,895<br>337<br>482,232<br>2,314<br>51,438<br>-<br>51,438<br>356,931<br>408,369|**Total funds**<br>**2025**<br>**£**<br>3,551<br>529,890|
|---|---|---|---|---|
|||||533,441|
|||||444,758<br>743|
|||||445,501|
|||||782|
|||||88,723|
|||||-|
|||||88,723|
|||||268,208|
|||||356,931|



The statement of financial activities includes all gains and losses recognised in the year. 

All income and expenditure derive from continuing activities. 

Page 10 



## **British Association of Urological Nurses Company Limited by Guarantee Statement of financial position For the year ended 31 March 2026** 

|**Notes**<br>**Fixed assets**<br>Tangible fixed assets<br>8<br>Intangible fixed assets<br>9<br>Investments<br>10<br>**Current assets**<br>Debtors<br>11<br>Cash at bank and in hand<br>Creditors: amounts falling due within one year<br>12<br>Net current assets<br>Total assets less current liabilities<br>Net assets<br>**Funds of the charity**<br>Restricted funds<br>Unrestricted funds<br>**Total charity funds**<br>13|**£**<br>233,847<br>408,524|**2026**<br> <br>**£**<br>75<br>7,503<br>25,786<br>33,364<br> <br> <br> <br> <br>375,005<br>408,369<br>408,369<br>14,369<br>394,000<br>408,369|**£**<br>172,286<br>296,250|**2025**<br> <br>**£**<br>88<br>-<br>23,472|
|---|---|---|---|---|
|||||23,560<br> <br> <br>333,371<br>356,931<br>356,931|
||642,371<br>267,366||468,536<br>135,165||
||||||
||||||
|||||14,606<br>342,325|
|||||356,931|



For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. 

The trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. 

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476. 

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime. 

The financial statements were approved by the board of trustees on 22.10.2026 and authorized for issue on and are signed on its behalf by: 


**Emma Chappel President Company Registration No. 07266955** 

Page 11 



**British Association of Urological Nurses Company Limited by Guarantee Statement of cash flows For the year ended 31 March 2026** 

|**Notes**<br>**Cash Flows from operating activities**<br>Net Expenditure (income) for the year<br>Adjustments for:<br>Depreciation Charge<br>8<br>Amortisation charge<br>9<br>Losses / (gains) on investments<br>10<br>Decrease/ (Increase) in debtors<br>Increase / (decrease) in creditors<br>**Net cash generated by operating activities**<br>**Cash Flows from investing activities**<br>Purchase of fixed assets<br>9<br>**Net Cash generated by investing activities**<br>**Change in cash and cash equivalents in the year**<br>**Cash and cash equivalents at beginning of the year**<br>19<br>**Cash and cash equivalents at the end of the year**||**2026**<br>**£**<br>51,438<br>13<br>2,846<br>(2,314)<br>(61,561)<br>132,201<br>122,623<br>(10,349)<br>(10,349)<br>112,274<br>296,250<br>408,524||**2025**<br>**£**<br>**As restated**<br>88,723<br>16<br>-<br>(782)<br>(19,939)<br>14,409|
|---|---|---|---|---|
|||||82,427|
|||||-|
|||||-|
|||||82,427<br>213,823|
|||||296,250|



## **Please see note 20 to the accounts for further details of prior period restatement** 

The notes on pages 13 to 20 form part of these financial statements. All income and expenditure derives from continuing activities 

Page 12 



**British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements For the year ended 31 March 2026** 

## **1. Accounting Policies** 

## **Company information** 

The charity is a private company limited by guarantee, registered in England and Wales and a registered charity in England. The address of the registered office is 71 Queen Victoria Street, London, EC4V 4BE, England. 

## **1.1 Accounting convention** 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - Charities SORP (FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. 

The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes. 

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. 

## **1.2 Going Concern** 

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements. 

## **1.3 Income and expenditure** 

Income representing membership subscriptions, sales of conference tickets and exhibition space, interest and branch income receivable is accounted for on an accruals basis. Donations and gift aid claims are recognised on receipt of proceeds. 

Resources expended are included in the statement of financial activities on an accruals basis. 

All costs have been directly attributed to one of the functional categories of resources expended in the statement of financial activities as follows: 

## **Charitable activities** 

These are costs relating to expenditure on preserving and maintaining the assets of the charity and the associated trade. 

## **Other expenditure** 

These are costs associated with the running of the regional branches of the charity. 

## **1.4 Cash and cash equivalents** 

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. 

Page 13 



**British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements (continued) For the year ended 31 March 2026** 

## **1. Accounting Policies (continued)** 

## **1.5 Tangible assets** 

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. 

## **Depreciation** 

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows: 

Fixtures & Fittings 

15% reducing balance 

## **Investments** 

Listed equity investments are initially recorded at cost, and subsequently measured at fair value. If fair value cannot be reliably measured, assets are measured at cost less impairment. 

Listed investments are measured at fair value with changes in fair value being recognised in income or expenditure. 

## **Impairment of fixed assets** 

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. 

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. 

## **1.6 Intangible Assets** 

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. 

All intangible assets are considered to have a finite useful life. Amortisation is provided as follows: 

Website 33% Reducing Balance 

## **1.7 Financial instruments** 

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument. 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. 

Page 14 



**British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements (continued) For the year ended 31 March 2026** 

## **1.8 Fund accounting** 

The funds of the charity are held in unrestricted and restricted funds. Unrestricted funds represent funds which can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds represent funds which must be used in accordance with the specific objectives that were laid out by those parties providing the funds to the charity. 

## **1.9 Taxation** 

The company is a registered charity and is not liable for United Kingdom income tax or corporation tax on charitable activities. 

## **2. Limited by guarantee** 

British Association of Urological Nurses is a company limited by guarantee and accordingly does not have share capital. Every member of the company undertakes to contribute such amount as may be required not exceeding £10 to the assets of the charitable company in the event of its being wound up while he or she is a member, or within one year after he or she ceases to be a member. 

In accordance with FRS 102 and the Charities SORP, the trustees of this company limited by guarantee make estimates and judgements that affect the reported amounts in the financial statements. These are based on reasonable assumptions and historical experience. Actual results may differ from these estimates. 

## **3. Employees** 

The average monthly number of persons (including directors) employed by the company during the year was: 

|Total<br>**4. Income from donations and legacies**<br>Donations and Legacies|**Unrestricted**<br>**£**<br>**Restricted**<br>**£**<br>2,412<br>100|**2026**<br>**Number**|**2025**<br>**Number**|
|---|---|---|---|
|||0|0|
|||**Total 2026**<br>**£**<br> <br>2,512|**Total 2025**<br>**£**<br>3,551|



## **5. Income from Charitable activities** 

|AGM and conference income<br>Advertising income<br>Members subscriptions<br>Corporate subscriptions<br>Royalties income<br>Study Day income|**2026**<br>**2025**<br>**£**<br>**£**<br>386,746<br>404,383<br>31,833<br>27,342<br>45,267<br>45,819<br>26,250<br>23,250<br>27,585<br>14,256<br>11,163<br>14,840|
|---|---|
||528,844<br>529,890|



Page 15 



## **British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements (continued) For the year ended 31 March 2026** 

|**6. Expenditure**<br>**Charitable activities**<br>Conference expenses<br>Education<br>Newsletter<br>Membership<br>Direct mailing & website costs<br>Support costs<br>Study Day expenses<br>**Other expenditure**<br>**Support costs**<br>General office<br>Governance costs<br>Administration<br>Printing, postage, advertising & stationery<br>Irrecoverable VAT<br>Insurance<br>Depreciation<br>Bad debt write off<br>**7. Independent examination fees**<br>Fees payable to the independent examiner for:<br>Independent examination of the financial statements<br>**8. Tangible Fixed Assets**<br>Cost:<br>At 1 April 2025<br>Additions<br>At 31 March 2026<br>Depreciation:<br>At 1 April 2025<br>Charge for the period<br>At 31 March 2026<br>Net Book Value:<br>As at 31 March 2026<br>As at 31 March 2025|**Unrestricted**<br>**Restricted**<br>**£**<br>**£**<br>322,742<br>-<br>3,375<br>-<br>10,743<br>-<br>22,558<br>-<br>4,006<br>-<br>91,747<br>-<br>26,724<br>-<br>-<br>337|**Total 2026**<br>**Total 2025**<br>**£**<br>**£**<br>322,742<br>296,963<br>3,375<br>1,227<br>10,743<br>6,749<br>22,558<br>22,682<br>4,006<br>2,607<br>91,747<br>92,430<br>26,724<br>22,100<br>337<br>743|
|---|---|---|
||481,895<br>337|482,232<br>445,501|
|||12,740<br>13,975<br>4,800<br>5,225<br>59,258<br>54,692<br>413<br>750<br>7,233<br>9,783<br>3,281<br>3,618<br>2,859<br>16<br>1,163<br>4,371|
|||91,747<br>92,430|
|||**2026**<br>**2025**<br>**£**<br>**£**|
|||4,200<br>3,700|
|||**Fixtures & fittings**<br>**Total**<br>**£**<br>**£**<br>1,012<br>-<br>1,012<br>-|
|||1,012<br>1,012<br>924<br>924<br>13<br>13|
|||937<br>937<br>75<br>75|
|||88<br>88|



Page 16 



## **British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements (continued) For the year ended 31 March 2026** 

## **9. Intangible Fixed Assets** 

|**9. Intangible Fixed Assets**|||
|---|---|---|
|Cost:<br>At 1 April 2025<br>Additions<br>At 31 March 2026<br>Amortisation:<br>At 1 April 2025<br>Charge for the period<br>At 31 March 2026<br>Net Book Value:<br>As at 31 March 2026<br>**10. Investments**<br>Valuation 1 April 2025<br>Fair value movements<br>Disposals<br>Valuation 31 March 2026<br>**11. Debtors**<br>Trade debtors<br>Prepayments & Accrued Income<br>Other debtors<br>**12. Creditors: amounts falling due within one year**<br>Trade creditors<br>Accruals & deferred income<br>Other creditors<br>**Analysis of deferred income account**<br>Memberships<br>Conference|**Website**<br>**£**<br>-<br>10,349|**Total**<br>**£**<br>-<br>10,349|
||10,349<br>-<br>2,846|10,349<br>-<br>2,846|
||2,846<br>7,503|2,846<br>7,503|
||**2026**<br>**£**<br>197,978<br>35,869<br>-|**Other investments**<br>**£**<br>23,472<br>2,314<br>-|
|||25,786|
|||**2025**<br>**£**<br>90,601<br>72,124<br>9,561|
||233,847|172,286|
||**2026**<br>**£**<br>13,149<br>238,741<br>15,476|**2025**<br>**£**<br>45,930<br>89,020<br>215|
||267,366|135,165|
||31,597<br>199,960|30,824<br>53,196|
||231,557|84,020|



During the year brought forward deferred income of £84,020 was released to the statement of financial activities and a further £231,557 of income was deferred. 

Page 17 



## **British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements (continued) For the year ended 31 March 2026** 

**13. Analysis of charitable funds** 

|**Unrestricted funds**<br>General funds<br>Designated funds -<br>Fixed assets<br>**Restricted funds**<br>Bruce Turner Legacy<br>Catherine Atkin|**As at 1 April 2025**<br>**£**<br>342,237<br>88|<br>**Income**<br>**Expenditure**<br>**Transfers**<br>**Gains and losses**<br> <br>**£**<br>**£**<br>**£**<br>**£**<br>531,256<br>(479,036)<br>(10,349)<br>2,314<br>-<br>10,349<br>-<br>(2,859)|**As at 31 March 2026**<br>**£**<br>386,422<br>7,578|
|---|---|---|---|
||342,325<br>13,250<br>1,356|531,256<br>(481,895)<br>-<br>2,314<br>100<br>(337)<br>-<br>-<br>-<br>-<br>-<br>-|394,000<br>13,013<br>1,356|
||14,606|100<br>(337)<br>-<br>-|14,369|
||356,931|531,356<br>(482,232)<br>-<br>2,314|408,369|



Bruce Turner Legacy Fund: This fund is a restricted fund to be used for training. Catherine Atkin Memorial fund: This fund is to be used for support the EFUN Educational project 

## **14. Transactions with trustees** 

No trustees received remuneration in the year. 

Travel and subsistence expenses reimbursed to trustees or paid directly to third parties totalled £2,373 (2025:£160). 

## **15. Analysis of net assets between funds** 

|Tangible fixed assets<br>Intangible fixed assets<br>Investments<br>Current assets<br>Creditors less than 1 year<br>**Net assets**|**Unrestricted**<br>**funds**<br>**Restricted funds**<br>**Total Funds 2026**<br>**Total Funds 2025**<br>**£**<br>**£**<br>**£**<br>**£**<br>75<br>-<br>75<br>88<br>7,503<br>-<br>7,503<br>-<br>11,417<br>14,369<br>25,786<br>23,472<br>642,371<br>-<br>642,371<br>468,536<br>(267,366)<br>-<br>(267,366)<br>(135,165)|
|---|---|
||<br> <br> <br>394,000<br>14,369<br>408,369<br>356,931|



Page 18 



## **British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements (continued) For the year ended 31 March 2026** 

## **16. Comparative Statement of Financial Activities for the year ended 31 March 2025** 

|Income and endowments<br>Donations and legacies<br>Charitable activities<br>Total income<br>Expenditure on:<br>Charitable Activities<br>Other expenditure<br>Total expenditure<br>Net losses/(gains) on investments<br>Net income<br>Transfers between funds<br>Net movement in funds<br>Reconciliation of funds<br>Total funds brought forward<br>Total funds carried forward|**Unrestricted Funds**<br>**Restricted Funds**<br>**Total funds 2025**<br>**£**<br>**£**<br>**£**<br>3,551<br>-<br>3,551<br>529,890<br>-<br>529,890|
|---|---|
||533,441<br>-<br>533,441|
||444,758<br>-<br>444,758<br>-<br>743<br>743|
||444,758<br>743<br>445,501|
||782<br>-<br>782|
||89,466<br>(743)<br>88,723|
||-<br>-<br>-|
||89,466<br>(743)<br>88,723|
||252,859<br>15,349<br>268,208|
||342,325<br>14,606<br>356,931|



## **17. Company limited by guarantee** 

The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up while he or she is a member, or within one year after he or she ceases to be a member, is limited to £1. 

## **18. Going concern** 

At the date of approval, the trustees have prepared and approved up to date management accounts, budgets and cash flow projections which include key income and cost assumptions that the trustees consider reasonable and prudent. 

Having considered the matters above the trustees are of the view that, at the date of approval of the financial statements, the charity will have sufficient resources to continue to operate and meet debts as they fall due for the foreseeable future. The financial statements have therefore been drawn up on a going concern basis. 

Page 19 



## **British Association of Urological Nurses Company Limited by Guarantee Notes to the financial statements (continued) For the year ended 31 March 2026** 

|**19. Net Debt analysis**<br>Cash at bank and in hand|**At 1 April 2025**<br>**£**|**Cashflows**<br>**£**|<br>**At 31 March 2026**<br> <br>**£**|
|---|---|---|---|
||296,250|112,274|408,523|



## **20. Prior period error - Omission of statement of cash flows** 

During the preparation of the financial statements for the year ended 31 March 2026, the trustees identified that the financial statements for the year ended 31 March 2025 did not include a statement of cash flows. The charity was required to present a statement of cash flows in accordance with the applicable Charities SORP and FRS 102. 

The comparative information has been restated to include the statement of cash flows for the year ended 31 March 2025. 

The correction relates solely to the presentation and disclosure of the financial statements. There is no impact on the net income, total funds, net assets or cash balances previously reported by the charity. 

Page 20 

